Intellia Therapeutics, Inc. (NTLA)
USD 12.02
(-8.45%)
USD 12.02
(-8.45%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 36.27 Million | 52.12 Million | 33.05 Million | 57.99 Million | 43.1 Million | 30.43 Million |
| Cost of Revenue | 435.06 Million | 7.57 Million | 6.89 Million | 150.4 Million | 108.41 Million | 89.11 Million |
| Gross Profit | -398.79 Million | 44.54 Million | 26.16 Million | -92.41 Million | -65.31 Million | -58.68 Million |
| Operating Expenses | 551.56 Million | 510.28 Million | 300.9 Million | 194.57 Million | 149.47 Million | 121.3 Million |
| Selling, General and Administrative Expenses | 116.49 Million | 90.3 Million | 71.09 Million | 44.16 Million | 41.05 Million | 32.18 Million |
| Research and Development Expenses | 435.06 Million | 419.97 Million | 229.8 Million | 150.4 Million | 108.41 Million | 89.11 Million |
| Other Expenses | - | - | - | - | - | - |
| Cost and Expenses | 551.56 Million | 510.28 Million | 300.9 Million | 194.57 Million | 149.47 Million | 121.3 Million |
| Operating Income | -515.29 Million | -458.16 Million | -267.85 Million | -136.58 Million | -106.36 Million | -90.87 Million |
| Interest Expense | - | 8.54 Million | - | - | - | - |
| Income Tax Expense | - | 16.02 Million | -8.17 Million | -8.66 Million | -6.83 Million | 5.52 Million |
| Earnings before Tax | -481.19 Million | -474.18 Million | -267.89 Million | -134.23 Million | -99.53 Million | -85.34 Million |
| Net Income | -481.19 Million | -490.2 Million | -259.71 Million | -125.56 Million | -92.69 Million | -85.34 Million |
| Earnings Per Share Basic | -5.42 | -6.37 | -3.66 | -2.24 | -1.96 | -1.98 |
| Earnings Per Share Diluted | -5.42 | -6.37 | -3.66 | -2.24 | -1.96 | -1.98 |
| Weighted Average Shares Outstanding | 88.77 Million | 76.97 Million | 70.89 Million | 55.98 Million | 47.24 Million | 43.06 Million |
| Weighted Average Shares Outstanding (Diluted) | 88.77 Million | 76.97 Million | 70.89 Million | 55.98 Million | 47.24 Million | 43.06 Million |
| Gross Margin | -10.99 | 0.85 | 0.79 | -1.59 | -1.52 | -1.93 |
| EBIT Margin | -13.96 | -8.53 | -8.10 | -2.36 | -2.34 | -2.99 |
| Profit Margin | -13.27 | -9.41 | -7.86 | -2.17 | -2.15 | -2.80 |
| EBITDA | -506.31 Million | -450.59 Million | -260.95 Million | -130.27 Million | -100.78 Million | -86.4 Million |
| Earnings Before Tax Margin | -14.21 | -8.79 | -8.10 | -2.36 | -2.47 | -2.99 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 6.95 Million | 28.93 Million | -1.91 Million | 36.27 Million | 11.99 Million | 13.59 Million |
| Cost of Revenue | 2.59 Million | 2.51 Million | 2.46 Million | 8.97 Million | 2.29 Million | 2.17 Million |
| Gross Profit | 4.35 Million | 26.42 Million | -4.38 Million | 27.29 Million | 9.7 Million | 11.42 Million |
| Operating Expenses | 143.4 Million | 140.42 Million | 137.97 Million | 551.56 Million | 143.09 Million | 145.92 Million |
| Selling, General and Administrative Expenses | 31.79 Million | 31.09 Million | 28.99 Million | - | 29.4 Million | 30.65 Million |
| Research and Development Expenses | 111.6 Million | 109.33 Million | 108.98 Million | - | 113.69 Million | 115.27 Million |
| Other Expenses | -114.2 Million | - | - | - | - | - |
| Cost and Expenses | 146 Million | 142.93 Million | 137.97 Million | 551.56 Million | 143.09 Million | 145.92 Million |
| Operating Income | -139.04 Million | -114 Million | -139.89 Million | -515.29 Million | -131.1 Million | -132.33 Million |
| Interest Expense | - | - | 8.83 Million | - | - | - |
| Income Tax Expense | - | 2.46 Million | 40.63 Million | -49.73 Million | -15.03 Million | -14.82 Million |
| Earnings before Tax | -146.97 Million | -107.43 Million | -132.16 Million | -481.19 Million | -122.22 Million | -123.68 Million |
| Net Income | -146.97 Million | -107.43 Million | -132.16 Million | -481.19 Million | -122.22 Million | -123.68 Million |
| Earnings Per Share Basic | -1.52 | -1.12 | -1.46 | - | -1.38 | -1.40 |
| Earnings Per Share Diluted | -1.52 | -1.12 | -1.46 | - | -1.38 | -1.40 |
| Weighted Average Shares Outstanding | 96.97 Million | 95.5 Million | 90.46 Million | 88.77 Million | 88.64 Million | 88.18 Million |
| Weighted Average Shares Outstanding (Diluted) | 96.97 Million | 95.5 Million | 90.46 Million | 88.77 Million | 88.64 Million | 88.18 Million |
| Gross Margin | 0.63 | 0.91 | 2.29 | 0.75 | 0.81 | 0.84 |
| EBIT Margin | -19.61 | -3.85 | 71.69 | - | -10.93 | -9.73 |
| Profit Margin | -21.13 | -3.71 | 68.94 | -13.27 | -10.19 | -9.10 |
| EBITDA | -136.44 Million | -111.49 Million | -137.42 Million | - | -131.1 Million | -132.33 Million |
| Earnings Before Tax Margin | -19.99 | -3.94 | 72.97 | -14.21 | -10.93 | -9.73 |
6698
VPHIF
VNUE
E4C
ICE
VSBGF